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Actionable Patient Safety Solution (APSS) #3C:
IMPROVE PREVENTION OF SEVERE HYPOGLYCEMIA
Executive Summary Checklist
Severe hypoglycemia (SH) causes significant morbidity and occasional mortality in hospitalized patients. The
establishment of an effective program to reduce errors in the recognition and treatment of SH requires an
implementation plan that includes the following actionable steps:
▢

Establish a commitment from hospital administration and medical leadership to reduce SH.

▢

Raise institutional awareness of the issue by comparing hospital and nursing units based on performance
quality scorecards.

▢

Create a multidisciplinary team that includes physicians, pharmacists, nurses, diabetic educators,
medication safety officers, case managers, and long-term healthcare professionals. This team will:

▢

●

Develop a system to identify patients receiving anti-diabetic medications (sulfonylureas, insulins,
etc.) in the Electronic Health Record (EHR).

●

Implement real-time surveillance methods, analysis tools, and point-of-care blood glucose (BG)
monitoring and reporting systems.

●

Create insulin order sets that could be modified to reduce risks of hypoglycemia.

●

Coordinate glucose monitoring, automate insulin dose calculations, insulin administration, and
meal delivery during changes of shift and times of patient transfer.

●

Develop a systematic approach to reduce SH and implement universal best practices.

Continuously monitor the incidence of SH in the hospital, and use the results of this monitoring in medical
staff education sessions as a part of Continuous Quality Improvement (CQI).
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The Performance Gap
Hypoglycemia is a common problem for many patients with diabetes, and it can also occur in non-diabetics in a
hospital setting. . Mild episodes can cause unpleasant symptoms and disrupt daily activities. Severe hypoglycemia
(SH) can result in disorientation and unusual behavior, and may be life-threatening. Frequent hypoglycemia is
associated with increased morbidity, length of stay, and mortality. Hypoglycemia has been associated with mortality
in the intensive care units.1 Moderate and SH are strongly associated with increased risk of death, especially from
distributive shock.2 This is by means of impairment of autonomic function, alteration of blood flow and
composition, white cell activation, vasoconstriction, and the release of inflammatory mediators and cytokines.3,4
The prevalence of hypoglycemia (serum glucose <70 mg/dL) was reported as 5.7% of all point-of-care blood
glucose (BG) tests in a 2009 survey of 575 hospitals.5 The definition of SH (a low BG level that requires the
assistance of another person for recovery), is a level <40 mg/dL, has been adopted as the level likely to cause harm
in the hospital setting.6 SH is a preventable harm. Early therapeutic management of mild hypoglycemia can prevent
more SH episodes. In addition, literature showed that clinicians do not consistently adjust their patient’s antidiabetic regimens appropriately following treatment of hypoglycemia, placing the patient at additional risk.7,8
Causative factors that may lead to the development of hypoglycemia for inpatients may include excessive insulin
dose, inappropriate timing of insulin or anti-diabetes therapy, unaddressed antecedent hypoglycemia or changes in
the nutritional regimen, creatinine clearance changes, or steroid dose (9).9 Failure of effective BG monitoring and
communication between physicians, pharmacists and nurses can also contribute to the problem. The diverse nature
of potential errors in the treatment of inpatients with SH supports the need for a decision-making model that can be
used to predict and prevent SH episodes and improve overall patient safety and outcomes.
Closing the performance gap will require hospitals and healthcare systems to commit to action in the form of
specific leadership, practice, and technology plans.

1

Elliott, M. B., Schafers, S. J., McGill, J. B., & Tobin, G. S. (2012). Prediction and prevention of treatment-related
inpatient hypoglycemia. Journal of Diabetes Science and Technology, 6(2), 302-309.
2
NICE-Sugar Study Investigators. (2012). Hypoglycemia and risk of death in critically ill patients. New England
Journal of Medicine, 2012(367), 1108-1118.
3
Adler, G. K., Bonyhay, I., Failing, H., Waring, E., Dotson, S., & Freeman, R. (2009). Antecedent hypoglycemia
impairs autonomic cardiovascular function implications for rigorous glycemic control. Diabetes, 58(2), 360-366.
4
Wright, R. J., & Frier, B. M. (2008). Vascular disease and diabetes: is hypoglycaemia an aggravating factor?.
Diabetes/Metabolism Research and Reviews, 24(5), 353-363
5
Swanson, C., Potter, D., Kongable, G., & Cook, C. (2011). Update on inpatient glycemic control in hospitals in the
United States. Endocrine Practice.
6
Schwartz, A. V., Vittinghoff, E., Sellmeyer, D. E., Feingold, K. R., De Rekeneire, N., Strotmeyer, E. S., ... &
Faulkner, K. A. (2008). Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care,
31(3), 391-396.
7
Boucai, L., Southern, W. N., & Zonszein, J. (2011). Hypoglycemia-associated mortality is not drug-associated but
linked to comorbidities. The American Journal of Medicine, 124(11), 1028-1035.
8
DiNardo, M., Noschese, M., Korytkowski, M., & Freeman, S. (2006). The medical emergency team and rapid
response system: Finding, treating, and preventing hypoglycemia. Joint Commission Journal on Quality and Patient
Safety/Joint Commission Resources, 32(10), 591.
9
Deal, E. N., Liu, A., Wise, L. L., Honick, K. A., & Tobin, G. S. (2011). Inpatient insulin orders: Are patients
getting what is prescribed?. Journal of Hospital Medicine, 6(9), 526-529.
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Leadership Plan
●
●
●
●
●
●

The plan must include the fundamentals of change outlined in the National Quality Forum safe practices,
including awareness, accountability, ability, and action.10
Hospital governance and senior administrative leadership (medical, pharmacy, and nursing) must fully
understand the performance gaps in their own healthcare system.
Hospital governance, senior administrative leadership, and clinical/safety leadership must close their own
performance gaps by implementing a comprehensive approach.
Hospitals should set a goal date for the implementation of the corrective plan, with measurable quality
indicators and milestones.
Specific budget allocations for the plan should be evaluated by governance boards and senior
administrative leaders.
Clinical/safety leadership should endorse the plan and ensure implementation across all providers and
systems.

Practice Plan
● Each hospital should create a multidisciplinary team, which includes physicians, pharmacists, nurses,
diabetic educators, medication safety officers, case managers, and long-term healthcare professionals).
● Develop a systematic approach to reducing severe hypoglycemia:
○ Identify events and prioritize
○ Raise institutional awareness
■ Compare hospitals and nursing units based on performance quality scorecards (use harm
rate for at-risk patient days: # of events/# of patient days during hospital stay when a
diabetic agent is ordered at any time)
○ Encourage nurses to enter hypoglycemia into safety event self-reporting site
○ Communicate to the hospital leadership board
○ Send letters to physicians and providers (from case managers)
○ Educate hospital staff, providers and patients – hospital newsletter and posters made for each
hospital/nursing unit listing known and assumed solutions to hypoglycemia (e.g., “STOP
Hypoglycemia!”)
○ Kickoff reception for safety initiative
○ Frequent monitoring of glucose levels in patients who are at risk.
● Implement foundational Best Practices and “Just Do Its” (Appendices A and B)
○ Establish a Hypoglycemia Task Force for the hospital
○ Propose multidisciplinary diabetes safety team at each hospital
○ Adopt foundational best practices (literature-based recommendations for all hospitals)
○ Implement “Just Do Its!” (or “Start Nows”) – these should be safe and reasonable interventions
tested internally
○ Adopt ISMP recommendations for U-500 insulin precautions (Appendix C)
● Event investigation and collect causative factors
○ Causative Factors (to consider as part of analysis tool):
■ Insulin stacking
■ Wrong drug, dose, route, patient, or time
■ Insufficient glucose monitoring
■ Basal heavy regimen
■ Decreased nutritional intake
■ Event related to outpatient or emergency department drug administration
■ Event while treating elevated potassium
■ Glucose trend not recognized
■ High dose sliding scale insulin
10

National Quality Forum. (2010). Safe practices for better healthcare–2010 update. Retrieved from:
http://www.qualityforum.org/publications/2010/04/safe_practices_for_better_healthcare_%E2%80%93_2010_updat
e.aspx
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●

■ Home regimen continued as inpatient
■ Significant reduction in steroid dose
■ Sulfonylurea-related hypoglycemia
■ Insulin administration and food intake not synchronized
■ POC glucose reading not linked to insulin administration
■ POC glucose reading not synchronized with food intake
○ Analysis tool forms reviewed by either pharmacist and/or nurse in a timely manner (e.g., 72 hours)
for causative factors; communicate findings with physician(s)
○ Results are collated and reported to Medication Safety Committee and the Pharmacy and
Therapeutics Committee
○ Identify interventions (evidence-based and expert opinion) that are used to resolve the most
common or most harmful causative factors
○ Track the interventions and create customized action plans based on an integrated results
dashboard
○ Share best practices within hospital and to other hospitals
Share strategies and implement informed interventions on target floors and patients.

Technology Plan
Suggested practices and technologies are limited to those proven to show benefit or are the only known technologies
with a particular capability. As other options may exist, please send information on any additional technologies,
along with appropriate evidence, to info@patientsafetymovement.org.
●
●
●
●
●
●
●

Implement glycemic management clinical decision support for insulin therapy recommendation, based on
individual responses to insulin and designed for mitigation of all types of hypoglycemia.
○ This would include all of the following bullet points with significant additional safety features.
Implement real-time surveillance method for informatics alerts: “High-Risk Sulfonylurea Alert” and
“Hypoglycemia Risk Alert”.
Implement an automated hypoglycemia event analysis tool (to discover local causes of hypoglycemia and
guide future interventions).
Implement point-of-care BG monitoring and reporting systems, including quality assurance reports to audit
compliance with hypoglycemia management goals and restriction of insulin utilization.
Implement automated triggers for most common causative factors of hypoglycemia, an electronic tracking
system for SH events, interventions used and clinical outcomes.
Implement a results dashboard for each nursing unit within the hospital and Best Practices used to resolve
the hypoglycemic event(s).
Set restrictions for the prescribing of U-500 Regular Insulin to only specialists and under special
circumstances in CPOE.

System or Practice

Available Technology

ONC Meaningful Use Certified EHR system Electronic
Health Record (EHR) System with the following
capabilities:
● Computerized Physician Order Entry (CPOE)
● Drug-drug interaction check

The following EHR vendors have signed
the Patient Safety Movement Open Data
Pledge:11
● Cerner
● GE Healthcare

11

Patient Safety Movement Foundation. Healthcare Technology Pledges. Retrieved from:
http://patientsafetymovement.org/challenges-solutions/commitments-pledges/healthcare-technology-pledges/
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●
●

Drug-allergy interaction check
Clinical Decision Support tools (CDS)

FDA approved glycemic management clinical decision
support for insulin therapy recommendation, based on
individual patient’s response to insulin and designed for
mitigation of all types of hypoglycemia.

●

Monarch Medical Technologies
Endotool® Solutions

CPOE simulation tool to quantify the risk of serious ADEs
with your current system CPOE12,13

●

Leapfrog CPOE Evaluation Tool14

Drug Libraries

●
●
●
●
●
●

Alaris®
Baxter®
Hospira®
Fresenius®
B.Braun® I.V. pumps
BD Intelliport™ Medication
Management System for I.V.
injectables, or
comparable systems.

●
Pharmacy Workflow Manager

●

DoseEdge®
Healthcare®

12

from

Baxter

Leung, A. A., Keohane, C., Lipsitz, S., Zimlichman, E., Amato, M., Simon, S. R., ... & Seger, D. L. (2013).
Relationship between medication event rates and the Leapfrog computerized physician order entry evaluation tool.
Journal of the American Medical Informatics Association, 20(e1), e85-e90.
13
Metzger, J., Welebob, E., Bates, D. W., Lipsitz, S., & Classen, D. C. (2010). Mixed results in the safety
performance of computerized physician order entry. Health Affairs, 29(4), 655-663.
14
The Leapfrog Group. (2016). CPOE evaluation tool. Retrieved from:
http://www.leapfroggroup.org/sites/default/files/Files/CPOE_Instructions_20160624_1.pdf
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Appendix A: Summary of Foundational Best Practices15

Intervention

Rationale

Elevate awareness of hypoglycemia

Best in class and individual hospital initiatives to elevate awareness
on preventable harm have improved patient care.

Real time analysis (48 hours)

Pharmacy surveillance system provides information of when and
where these events occur, but not why they occur. Many hospitals
have had success lowering harm rate using this intervention.

Create and utilize diabetes
management team

AACE/ADA (American Association of Clinical
Endocrinologists/American Diabetes Association) noted creation of
a multidisciplinary steering committee guided by local diabetic
experts can establish reasonable and achievable glycemic
management goals.

Provide prescriber with tools to use
as a dosing guide

●
●

Nursing education process

●
●

Insulin dose timing coincide with
food intake

●
●

Improve POC glucose testing with
the insulin administration time

●

●
Utilize glucose management software

AACE/ADA suggests a systems approach for management
of inpatient glycemic control.
Can establish reasonable and achievable glycemic
management goals with use of protocols and order sets.
AACE/ADA noted a lack of ownership in diabetes care
may be due in part to insufficient knowledge or confidence
in diabetes management.
Improvements in care can be achieved by ongoing
education and training.
AACE/ADA noted many hospitals are challenged by poor
coordination of meal delivery and prandial insulin
administration.
A systems approach can promote the coordination of
glucose monitoring, insulin administration, and meal
delivery, particularly during change of shifts and times of
patient transfer.
AACE/ADA stated that bedside BG monitoring with use
of POC glucose meters should be performed before meals
and at bedtime in most inpatients who are eating usual
meals.
Important to avoid routine use of correction insulin at
bedtime.

Collective evidence showed a reduction in hypoglycemic events
through the use of glucose software management

15

Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., ... & Umpierrez, G. E.
(2009). American Association of Clinical Endocrinologists and American Diabetes Association consensus statement
on inpatient glycemic control. Diabetes Care, 32(6), 1119-1131.
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Appendix B: Just Do Its! Recommendations16

Modify insulin order set to hold insulin only with MD order

Just Do It!

Modify insulin order set to match pending electronic order set to reduce doses of
bedtime sliding scale (30% reduction)
Modify insulin order set to avoid routine correction insulin at specific times (e.g.,
0200 and 0400)
Modify insulin order set to match pending electronic order set to state: Notify MD
when hypoglycemic event occurs (2 levels <70 mg/dL or 1 level <50 mg/dL, or
>300 mg/dL)
Add Pharmacist and Endocrinologist on diabetes management team

Appendix C: Start Now: U-500 Regular Insulin Project16
Scope: Develop guidelines for injectable U-500 insulin to reduce ADE preventable harm. U-500 insulin is an
uncommon concentration, which if given with syringes designed for U-100 insulin can cause serious harm.
Preventable Harm: Risk potential and risk severity are both high
Resources: Pharmacist(s) and nurse(s)
Deliverable Goals:
● Develop standard High Alert or High Hazard Medication or restrictions for U-500 insulin at all hospitals to
prevent improper dosing and harm secondary to hypoglycemia.
● Develop policy that will safeguard or restrict the use of U-500 to specialists and special circumstances
Risks/Barriers:
● Hospitals that do not have the drug on formulary have not addressed patients using drug from home;
● Hospitals feel drug not on formulary will protect them from ADEs (Non-formulary does not equal no-risk
of ADE)

16

Milligan, P. E., Blackburn, M. C., Dachroeden, R. R. (2014). Multi- faceted improvement initiative to detect and
improve prevention of severe hypoglycemia. Retrieved from: http://www.ashp.org/DocLibrary/AbstractArchive/SM14-Session-Abstracts.pdf
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